Lactoferrin has become one of the most sought-after proteins in nutrition, prized for its breadth of functions that spans immune support, iron regulation, and gut health.
Lactoferrin has a strong natural affinity to bind iron. The amount of iron it carries, known as the level of iron saturation, determines the form of the protein. When lactoferrin is mostly loaded with iron, above roughly 80% saturation, it is in the iron-bound, or “holo”, form. Most lactoferrin sold today sits somewhere in between, in a partially saturated (10% to 20%) state. When iron saturation is below 5%, the protein is in its iron-free, or “apo”, form.
The form of lactoferrin matters and is a key differentiator when it comes to product formulation and ingredient benefits. The open, iron-hungry structure of apo-lactoferrin is thought to enable much of the protein’s signature work. It scavenges free iron from the gut and from inflamed tissue, denying bacteria the nutrients they depend on to grow, and it exposes the active surfaces that the body’s own cells recognize and respond to. Holo-lactoferrin, with its binding sites already occupied, behaves largely as a passive iron carrier and loses much of that functional edge. Based on publicly available commercial ingredient offerings as of June 2026, developed by All G, LFX™ is the only commercially available apo-lactoferrin ingredient, the iron-free form linked to lactoferrin’s most valuable effects. And because LFX is manufactured in the apo form, it carries the full potential of unoccupied binding sites into the finished product.
More than an iron supplement
Since apo-lactoferrin has unoccupied sites for iron binding, the protein form is best understood as an iron regulator rather than an iron source. Iron is essential but double-edged: too little impairs energy metabolism and immune function, while too much can drive the formation of reactive oxygen species and the oxidative stress that follows.
By binding and redistributing free iron rather than simply adding to the body’s iron load, apo-lactoferrin supports iron balance, moving the mineral toward where it is needed and away from where it does harm. This regulatory role, preserved in full by the low saturation of LFX, separates apo-lactoferrin from a conventional iron supplement.
Evidence shows benefits of apo form
Across the literature, iron saturation is recognised as a key determinant of lactoferrin’s biological activity, with evidence showing that apo- and holo-forms exhibit distinct structural, physicochemical and functional properties1-3. Emerging research suggests apo-lactoferrin may play a particularly important role in mechanisms such as antimicrobial and immune-related activity.
A recurring theme in this research is the role of iron saturation in influencing iron absorption, with evidence indicating that apo-lactoferrin may support the uptake of dietary iron, while the iron-loaded form offers little beyond the iron itself. For a formulator, this offers the potential to maintain or improve iron uptake while cutting the ferrous iron dose that drives the gut discomfort reported by many consumers.
Another strong mechanism is antimicrobial defence. Apo-lactoferrin works by binding the free iron that bacteria need to grow. That single mechanism gives it a functional advantage over the holo and other forms, including against common gut pathogens and stubborn biofilms. With its iron-binding sites already partially occupied, the partially saturated or holo form may be less functionally active.
The same pattern carries through lactoferrin’s wider repertoire of benefits. The apo form supports the integrity of the gut lining, activates immune cells more powerfully, and delivers stronger antioxidant protection while switching on the body’s own antioxidant defenses. In general, the lower the iron saturation, the more effective the protein. LFX is engineered to sit at the extreme end of low iron saturation, maximizing bioactivity.
Closing the gap between the science and the shelf
Until recently, apo-lactoferrin was not commercially available. Lactoferrin extracted from cow’s milk typically arrives at 10% to 20% iron saturation. The lactoferrin in human breast milk, the reference point for early-life nutrition, exists in a naturally low-saturation apo state that currently available lactoferrins do not match.
Most lactoferrin on the market has therefore been partially saturated or holo, not the apo form which a growing body of evidence points to. LFX closes that gap as the only commercially available apo-lactoferrin, manufactured to a consistently low saturation rather than corrected after the fact.
Stronger functional performance
Reaching a genuine apo state through traditional processing is difficult and costly, because it means stripping iron out of a protein that binds it readily. LFX takes a different route. It is produced by fermentation rather than extracted from milk.
This allows All G to manufacture it directly to a low-saturation specification: below 5% iron saturation, while also sustaining greater than 95% purity. Peer-reviewed analysis has shown LFX to be structurally and functionally equivalent to dairy-derived lactoferrin, with the low-saturation profile preserved.
“We’re not just matching traditional lactoferrin, we’re seeing stronger functional performance,” says Dr. Jared Raynes, chief scientific officer at All G.
Producing LFX in a closed system, rather than purifying it from milk, brings further formulation benefits: it carries no animal hormone or antibiotic residues, and supports vegan positioning. Supply and batch-to-batch consistency are also decoupled from dairy, bringing an end to the volatile pricing that used to be associated with lactoferrin.
Iron saturation is not the only number that matters
LFX is now available for formulation, is GRAS, and has received a “no questions” letter from the FDA for use in adult nutrition.
Iron saturation is not the only number that matters: the low-saturation specification of LFX sits alongside its high purity and neutral taste. The stable powder format suits dietary supplements, functional foods and beverages, and active nutrition, as well as women’s health, immune and gut formats, healthy-aging products.
The result is an apo-lactoferrin that lets brands formulate around the mechanism the evidence supports, and explains more precisely why a lactoferrin product works, not simply that it contains lactoferrin.
References
- Huang Y.; et al. Critical Importance of Iron Saturation in Lactoferrin: Effects on Biological Activity, Nutritional Functions, and Applications. Journal of Agricultural and Food Chemistry. 2025;73(18):10665-10680.
- Moore S A.; et al. Three-dimensional structure of diferric bovine lactoferrin at 2.8 A resolution. Journal of Molecular Biology 1997; 274(2):222-236.
- Bokkhim H.; et al. Physico-chemical properties of different forms of bovine lactoferrin. Food Chemistry. 2013;141(3):3007-3013.